Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on October 7, 2025
Global Clinical Trials Market 2025-2032 Forecast: Market Size USD 88.26 Billion Pharma, Biotech, Drug Development Trends
Global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032. WILMINGTON, DE, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- Global Clinical Trials Market was valued at USD 54.83 billion …
U.S. Corporate Wellness Market Set to Witness Significant Growth by 2025-2032 | Aquila, BSDI, Aduro, Active Wellness
U.S. Corporate Wellness Market is estimated to be valued USD 16.07 Bn in 2025 and expected reach USD 30.14 Bn by 2032, growing at CAGR of 9.4% from 2025 to 2032 BURLINGAME, CA, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- Coherent Market …
Multi-Cancer Early Detection Testing Market Driven by Precision Oncology and Healthcare Investments | DataM Intelligence
Explore the Multi-Cancer Early Detection Testing Market, driven by rising cancer prevalence, AI genomics, liquid biopsy, and precision oncology trends. AUSTIN, TX, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- According to DataM Intelligence, the …
Melatonin Industry Outlook: Key Innovations, USA-Japan Expansion & Competitive Landscape
Melatonin Market: Trends, Insights, and Strategic Outlook AUSTIN, NY, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- Market Overview The global melatonin market is experiencing significant growth, driven by increasing consumer awareness of …
5G Remote Surgery Market to Reach $5.23 Billion by 2029 with 30.6% CAGR
The Business Research Company's 5G Remote Surgery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 7, 2025 /EINPresswire.com/ -- What Is The 5G Remote Surgery Market Size And …
Abemaciclib Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends till 2029
The Business Research Company's Abemaciclib Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 7, 2025 /EINPresswire.com/ -- How Much Is The Abemaciclib Market Worth? The …
Academic Medical Center Market to Reach USD $802.21 Billion by 2029 at 12% CAGR
The Business Research Company's Academic Medical Center Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 7, 2025 /EINPresswire.com/ -- How Big Is The Academic Medical Center …
Adaptive Radiotherapy Software Market to Reach USD $1.19 Billion by 2029 at 14.1% CAGR
The Business Research Company's Adaptive Radiotherapy Software Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 7, 2025 /EINPresswire.com/ -- What Is The Estimated Industry …
Air Compression Leg Massager Market CAGR to be at 10.5% from 2025 to 2029 | $3.06 Billion Industry Revenue by 2029
The Business Research Company's Air Compression Leg Massager Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 7, 2025 /EINPresswire.com/ -- What Is The Projected Market Size …
Animal Digital Health Market Drivers 2025-2029: Regional Outlook and Sizing Analysis
The Business Research Company's Animal Digital Health Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, October 7, 2025 /EINPresswire.com/ -- Animal Digital Health Market Growth …
Triumph Steps Expands Emotional Literacy Programs to Schools Nationwide
Miami, Florida , Oct. 07, 2025 (GLOBE NEWSWIRE) -- Triumph Steps, an emotional literacy platform trusted by professionals and communities, today announced the national rollout of Triumph Steps for Schools, a comprehensive K–12 initiative designed to foster …
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners
CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)
- First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications or adverse events reported to date - - Data from this non-MTS cohort, together with results from Neurona’s ongoing Phase 1/2 …
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Nature’s Sunshine Relaunches Revolutionary Power Line to Combat Metabolic Health Crisis
LEHI, Utah, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the relaunch of its Power Line suite of …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing …
Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025
Présentation d’une comparaison entre histologie numérique et sur lame des biopsies de screening de l’étude de Phase 3 NATiV3 Présentation de pathologie numérique de données précliniques avec lanifibranor Daix (France), New York City (New York, United …
Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025
Presentation of a comparison between digital and glass slide histology from screening biopsies in the Phase 3 NATiV3 study Presentation of digital pathology data from preclinical studies with lanifibranor Daix (France), New York City (New York, United …